| Keywords: |
treatment outcome; cancer surgery; fluorouracil; placebo; multimodality cancer therapy; cancer adjuvant therapy; cancer patient; cancer radiotherapy; methotrexate; nuclear magnetic resonance imaging; recurrence risk; methodology; lymph node metastasis; lymph node dissection; preoperative evaluation; clinical practice; neoplasm recurrence, local; breast cancer; breast; tumor volume; editorial; breast neoplasms; retrospective study; tissue section; axillary lymph node; mammography; minimal residual disease; intraoperative period; partial mastectomy; surgeon; clinical evaluation; reoperation; comorbidity; carcinoma; tamoxifen; medical practice; frozen section; intraductal carcinoma; frozen sections; mastectomy, segmental; north america; adipose tissue; patient preference; meta analysis (topic); sentinel lymph node metastasis; estrogen receptor positive breast cancer
|
